HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alison G Abraham Selected Research

Iohexol (Omnipaque)

10/2015Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study.
1/2014HIV therapy, metabolic and cardiovascular health are associated with glomerular hyperfiltration among men with and without HIV infection.
1/2014Factors affecting glomerular filtration rate, as measured by iohexol disappearance, in men with or at risk for HIV infection.
8/2013Blood lead level and measured glomerular filtration rate in children with chronic kidney disease.
9/2011Metabolic abnormalities, cardiovascular disease risk factors, and GFR decline in children with chronic kidney disease.
4/2011Extracellular volume and glomerular filtration rate in children with chronic kidney disease.
1/2010Optimizing iohexol plasma disappearance curves to measure the glomerular filtration rate in children with chronic kidney disease.
11/2009Longitudinal formulas to estimate GFR in children with CKD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alison G Abraham Research Topics

Disease

16Acquired Immunodeficiency Syndrome (AIDS)
10/2018 - 07/2011
14Chronic Renal Insufficiency
09/2021 - 11/2009
10HIV Infections (HIV Infection)
01/2022 - 04/2009
7Inflammation (Inflammations)
10/2021 - 10/2015
6Kidney Diseases (Kidney Disease)
09/2021 - 04/2011
5Anemia
01/2017 - 09/2011
4Hepatitis C
01/2019 - 04/2013
4Proteinuria
01/2018 - 08/2013
3COVID-19
01/2022 - 02/2021
3Infections
01/2017 - 06/2013
3Hypertension (High Blood Pressure)
02/2016 - 01/2014
3Dyslipidemias (Dyslipidemia)
06/2015 - 06/2013
2Diabetes Mellitus
01/2022 - 01/2021
2Cognitive Dysfunction
01/2021 - 01/2018
2Coinfection
01/2019 - 04/2017
2Viremia
11/2018 - 04/2013
2Obesity
07/2017 - 01/2016
2Acidosis
01/2017 - 09/2011
1Atherosclerosis
10/2022
1Ganglion Cysts (Ganglion)
01/2022
1Retinal Diseases
01/2022
1COVID-19 breakthrough infections
01/2022
1Rheumatoid Arthritis
01/2022
1Breakthrough Infections
01/2022
1Multiple Sclerosis
01/2022
1Prediabetic State (Prediabetes)
01/2021
1Frailty
10/2020
1Malnutrition (Nutritional Deficiencies)
01/2020
1Clostridium Infections
01/2019
1Dementia (Dementias)
01/2019
1Dysbiosis
01/2019
1Alzheimer Disease (Alzheimer's Disease)
01/2018
1Drug Overdose
01/2018
1Substance-Related Disorders (Drug Abuse)
01/2018
1Disease Progression
03/2017
1Vitamin D Deficiency
01/2017
1Noncommunicable Diseases
01/2017
1Hypercholesterolemia
01/2016
1Secondary Hyperparathyroidism
01/2016
1Hypoalbuminemia
06/2015
1Albuminuria
10/2014
1Cardiovascular Diseases (Cardiovascular Disease)
10/2014
1Hyperglycemia
01/2014

Drug/Important Bio-Agent (IBA)

10Biomarkers (Surrogate Marker)IBA
10/2021 - 11/2009
8Iohexol (Omnipaque)FDA Link
10/2015 - 11/2009
5Hemoglobins (Hemoglobin)IBA
01/2022 - 12/2012
5hydroxide ionIBA
10/2018 - 01/2016
5CreatinineIBA
01/2018 - 04/2011
4Retinaldehyde (Retinal)IBA
01/2022 - 01/2018
4Vitamin DFDA LinkGeneric
10/2018 - 01/2016
425-hydroxyvitamin DIBA
10/2018 - 01/2016
4Proteins (Proteins, Gene)FDA Link
01/2018 - 07/2011
31,25-dihydroxyvitamin DIBA
11/2017 - 01/2016
3RNA (Ribonucleic Acid)IBA
04/2015 - 04/2013
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2021
2Urokinase Plasminogen Activator ReceptorsIBA
09/2021 - 01/2020
2CytokinesIBA
02/2021 - 01/2016
2AntibodiesIBA
02/2021 - 07/2011
2Phosphates (Orthophosphate)IBA
01/2017 - 09/2011
2Ritonavir (Norvir)FDA Link
01/2017 - 02/2016
2PotassiumIBA
01/2017 - 09/2011
2Tenofovir (Viread)FDA Link
02/2016 - 05/2013
2LipidsIBA
10/2013 - 06/2013
1insulin receptor-related receptor (IRR)IBA
01/2022
1AntigensIBA
12/2021
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2021
1Epidermal Growth Factor (EGF)IBA
10/2021
1ChemokinesIBA
02/2021
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2020
1Viral RNAIBA
01/2019
1Illicit Drugs (Recreational Drugs)IBA
01/2019
1Hypnotics and Sedatives (Sedatives)IBA
01/2018
1Opioid Analgesics (Opioids)IBA
01/2018
1Prescription DrugsIBA
01/2018
1SodiumIBA
07/2017
1Triglycerides (Triacylglycerol)IBA
04/2017
1HDL CholesterolIBA
04/2017
1Interleukin-18 (Interleukin 18)IBA
04/2017
1Angiotensin IIIBA
01/2017
1Immunologic Factors (Immunomodulators)IBA
01/2017
1ReninIBA
01/2017
1AldosteroneIBA
01/2017
1Pharmaceutical PreparationsIBA
02/2016
1MineralsIBA
01/2016
1CalciumIBA
01/2016
1C-Reactive ProteinIBA
01/2016
1Lipopolysaccharide ReceptorsIBA
01/2016
1Cytokine Receptor gp130IBA
01/2016
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2016
1Serum AlbuminIBA
10/2014
1Zidovudine (Retrovir)FDA LinkGeneric
01/2014

Therapy/Procedure

7Therapeutics
01/2019 - 04/2009
6Highly Active Antiretroviral Therapy (HAART)
11/2018 - 05/2013
4Art Therapy
01/2017 - 01/2013
1Ambulatory Care (Outpatient Care)
10/2022
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2022
1Activities of Daily Living (ADL)
10/2020
1Fecal Microbiota Transplantation
01/2019
1Retention in Care
03/2017
1Renal Replacement Therapy (Therapies, Renal Replacement)
01/2017